Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
88 hedge funds and large institutions have $41.6M invested in Pernix Therapeutics Holdings, Inc. in 2016 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 25 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 26
13% less funds holding
Funds holding: 101 → 88 (-13)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
52% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 25
67% less capital invested
Capital invested by funds: $128M → $41.6M (-$86.2M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $17K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.88M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.45M |
| 3 |
AC
Armistice Capital
New York
|
+$1.16M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$556K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$476K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$2.49M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$2.07M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.75M |
| 4 |
Millennium Management
New York
|
-$1.49M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$1.49M |
PTX Hedge Fund Activity: Q1 2016 in Review
88 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q1 2016, worth a combined $41.6M — down 67% from $128M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of PTX and 12 opened new positions — a net loss of 13 holders — while 26 trimmed existing stakes and 28 added.
The largest buyer was Point72 Asset Management, adding an estimated $2.88M. The largest seller was Avoro Capital Advisors, cutting an estimated $2.49M.
- 88 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q1 2016, down from 101 in Q4 2015.
- Funds reported $41.6M of Pernix Therapeutics Holdings, Inc. stock for Q1 2016, down 67% quarter-over-quarter.
- 12 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q1 2016 and 25 closed out, a net change of -13 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q1 2016 was Point72 Asset Management, an estimated $2.88M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q1 2016 was Avoro Capital Advisors, an estimated $2.49M sold.
Based on aggregated 13F filings for Q1 2016.